Search

Your search keyword '"Dittrich, A.-M."' showing total 250 results

Search Constraints

Start Over You searched for: Author "Dittrich, A.-M." Remove constraint Author: "Dittrich, A.-M."
250 results on '"Dittrich, A.-M."'

Search Results

2. Endothelial derived, secreted long non-coding RNAs Gadlor1 and Gadlor2 aggravate cardiac remodeling

10. The Prevalence of Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma at One of the Largest Tertiary Care Centers in Sub-Saharan Africa

11. Skeletal muscle derived Musclin protects the heart during pathological overload

14. Update : COVID-19 Among Workers in Meat and Poultry Processing Facilities — United States, April–May 2020

19. Endothelial cells drive organ fibrosis in mice by inducing expression of the transcription factor SOX9

24. Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease – a lesson learned from cystic fibrosis

25. Abstract GS.06: The Fibrogenic Transcription Factor Sox9 Controls Mesenchymal Activation Of Endothelial Cells And Drives Fibrotic Disease

33. Secreted long non-coding RNAs Gadlor1 and Gadlor2 affect multiple cardiac cell types and aggravate cardiac remodeling during pressure overload

34. Increased IgA+ memory B cells are associated with small airway dysfunction in asthma patients

35. Application and external validation of the Asthma Severity Scoring System in children and adults

36. T2-high asthma across all ages – comparative analysis in children and adults from the ALLIANCE cohort

37. Clinical characteristics and evolution of allergen sensitization patterns in children with preschool wheeze and asthma of the ALLIANCE cohort

38. Collagen neoepitope biomarkers are increased in allergic broncho-pulmonary aspergillosis in Cystic Fibrosis

40. Impact of COVID-19 related alterations in circulating respiratory viruses on children and adult patients with recurrent wheeze and asthma

43. WS17.02 Long-term efficacy of lumacaftor/ivacaftor (LUM/IVA) in children aged 2 through 5 years with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation (F/F): a phase 2, open-label extension study

45. WS06.04 Effects of elexacaftor/tezacaftor/ivacaftor therapy on CFTR function in patients with cystic fibrosis and 1 or 2 F508del alleles

46. Clinical characteristics and evolution of allergen sensitization patterns in children with preschool wheeze and asthma of the ALLIANCE cohort

47. T2-high asthma across all ages - comparative analysis in children and adults from the ALLIANCE cohort

48. Application and external validation of the Asthma Severity Scoring System in children and adults

Catalog

Books, media, physical & digital resources